Skip to content

Immatics N.V.

IMTX

CIK 0001809196 · Biological Products, (No Diagnostic Substances) · Nasdaq

  • Immatics B.V. (until 2020-07-08)
← back to feed
Revenue (TTM)
—
FY Dec 2025
Net Income (TTM)
−€126.93M
−1,390.9% YoY FY Dec 2025
EPS Diluted (TTM)
−€1.29
−1,250.0% YoY FY Dec 2025
Gross Margin
—
FY Dec 2025
Operating Margin
—
FY Dec 2025
Net Margin
—
FY Dec 2025
Free Cash Flow (TTM)
—
FY Dec 2025
Cash
€345.92M
FY Dec 2025
Total Debt
—
FY Dec 2025
Shares Outstanding
134.07M sh
FY Dec 2025

Revenue & Net Income

EPS (Diluted)

Cash Flow

Revenue Growth (YoY)

No data available for this metric.

Balance Sheet

Cash vs Debt

Recent filings